T
TScan Therapeutics, Inc. (TCRX)
NGM – Real Time Price. Currency in USD
1.15
-0.03 (-2.54%)
At close: May 12, 2026, 4:00 PM EDT
Get all premium features to the best stock analysis tool
Find any stock by ticker or company name
NGM – Real Time Price. Currency in USD
1.15
-0.03 (-2.54%)
At close: May 12, 2026, 4:00 PM EDT
TScan Therapeutics, Inc., a clinical-stage biotechnology company, develops T cell receptor-engineered T cell (TCR-T) therapies for the treatment of patients with cancer in the United States. The company’s lead product is TSC-101, for the treatment of patients with acute myeloid leukemia (AML), myelodysplastic syndrome (MDS), and acute lymphoblastic leukemia (ALL) in patients undergoing allogeneic hematopoietic cell transplantation (HCT), which is in Phase I clinical trial, as well as eliminates residual disease and promotes donor chimerism. It also develops TSC-102-A01 and TSC-102-A03, which are allogeneic and donor-derived TCR-T therapy candidates targeting epitopes. In addition, the company develops TSC-200, TSC-201, TSC-202, TSC-203, and TSC-204 for the treatment of solid tumors. It has a research collaboration and license agreement with Amgen Inc. to identify antigens recognized by T cells in patients with Crohn’s disease. TScan Therapeutics, Inc. was incorporated in 2018 and is headquartered in Waltham, Massachusetts.
| Name | Position |
|---|---|
| Dr. Chrystal U. Louis M.D., M.P.H. | Chief Medical Officer |
| Dr. Gavin MacBeath Ph.D. | CEO & Director |
| Dr. Shrikanta Chattopadhyay M.D. | Senior VP & Head of Translational Medicine |
| Dr. Stephen J. Elledge Ph.D. | Co-Founder & Chairman of Scientific Advisory Board |
| Dr. Zoran Zdraveski J.D., Ph.D. | Chief Legal & Strategy Officer and Company Secretary |
| Mr. Jason A. Amello CPA | CFO, Treasurer, Principal Financial Officer & Principal Accounting Officer |
| Mr. Jim Murray | Chief Development Operations Officer |
| Mr. Ray Lockard M.B.A. | Chief Manufacturing & Quality Officer |
| Mr. Tomasz Kula Ph.D. | Co-Founder & Member of Advisory Board |
| Ms. Ann Hargraves | Chief Human Resources Officer |
| Date | Type | Document |
|---|---|---|
| 2026-05-06 | 8-K | tcrx-20260506.htm |
| 2026-05-06 | 10-Q | tcrx-20260331.htm |
| 2026-04-17 | DEF 14A | d26976ddef14a.htm |
| 2026-04-17 | ARS | d26610dars.pdf |
| 2026-04-07 | PRE 14A | d26976dpre14a.htm |
| 2026-04-02 | 8-K | d923169d8k.htm |
| 2026-03-04 | 8-K | tcrx-20260304.htm |
| 2026-01-12 | 8-K | d91709d8k.htm |
| 2025-11-26 | 8-K | d41366d8k.htm |
| 2025-11-12 | 8-K | tcrx-20251112.htm |